Ebola virus disease: Focus on children

Pediatric Infectious Disease Journal

Volumn 34, Issue 8, 2015, Pages 893-897

  Kourtis, Athena P ^a   Appelgren, Kristie ^a   Chevalier, Michelle S ^a   Mcelroy, Anita ^b,c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

children; Ebola virus disease; infants

Indexed keywords

ARTICLE; CHILDHOOD DISEASE; CHILL; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE COURSE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEVER; HEADACHE; HUMAN; INCUBATION TIME; INFANT DISEASE; INFECTION CONTROL; INFECTION PREVENTION; LABORATORY DIAGNOSIS; LABORATORY TEST; MACULOPAPULAR RASH; MALAISE; MYALGIA; PATHOGENESIS; PATIENT CARE; POPULATION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; VIRUS TRANSMISSION; ADOLESCENT; ADULT; AFRICA; CHILD; FEMALE; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA, WESTERN; CHILD; CHILD, PRESCHOOL; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFANT; INFANT, NEWBORN; MALE; YOUNG ADULT;

EID: 84937436054     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000707     Document Type: Article

References (52)

1. Curtis N. Viral hemorrhagic fevers caused by Lassa, Ebola and Marburg viruses. In: Pollard AJ, Finn A, eds. Hot Topics in Infection and Immunity in Children. New York: Springer; 2006: 35-44
2. Centers for Disease Control and Prevention (CDC). Outbreaks chronology: Ebola virus disease 2014. Available at: http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html. Accessed November 30, 2014
3. Bray M. Epidemiology, pathogenesis, and clinical manifestations of Ebola and Marburg virus diseases September 18, 2014; 2014
4. Frieden TR, Damon I, Bell BP, et al. Ebola 2014-new challenges, new global response and responsibility. N Engl J Med. 2014; 371: 1177-1180
5. Centers for Disease Control and Prevention (CDC). 2014 Ebola outbreak in West Africa-case counts 2014. Available at: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-Africa/case-counts.html. Accessed November 30, 2014
6. Team WHOER. Ebola virus disease in West Africa-The first 9 months of the epidemic and forward projections. N Engl J Med. 2014; 371: 1485-1491
7. World Health Organization (WHO). WHO: Ebola response roadmap situation report 2014. Available at: http://apps.who.int/iris/bitstream/10665/133833/1/roadmapsitrep4-eng.pdf?ua=1. Accessed November 30, 2014
8. Pigott DM, Golding N, Mylne A, et al. Mapping the zoonotic niche of Ebola virus disease in Africa. Elife. 2014; 3: e04395
9. Peters CJ. Marburg and Ebola virus hemorrhagic fever. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone/Elsevier; 2010: 2259-2263
10. Bell M. Ebola and Marburg hemorrhagic fever viruses. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Disease. 3rd ed. Philadelphia: Churchill Livingstone/Elsevier; 2008: 1138-1139
11. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission De Lutte contre les Epidemies a Kikwit. J Infect Dis. 1999; 179(Suppl 1): S87-S91
12. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999; 179(Suppl 1): S177-S187
13. Tomori O, Fabiyi A, Sorungbe A, et al. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg. 1988; 38: 407-410
14. Centers for Disease Control and Prevention (CDC). Estimating the future number of cases in the ebola epidemic-Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ. 2014; 63: 1-14
15. Pourrut X, Délicat A, Rollin PE, et al. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis. 2007; 196 (Suppl 2): S176-S183
16. Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature. 2005; 438: 575-576
17. Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission De Lutte contre les Epidemies a Kikwit. J Infect Dis. 1999; 179 (Suppl 1): S76-S86
18. World Health Organization (WHO). WHO: Ebola response roadmap situation report-15 October 2014. Available at: http://apps.who.int/iris/bitstream/10665/136508/1/roadmapsitrep15Oct2014.pdf?ua=1. Accessed October 16, 2014
19. Breman JG, Johnson KM. Ebola then and now. N Engl J Med. 2014; 371: 163-166
20. Wamala JF, Lukwago L, Malimbo M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis. 2010; 16: 1087-1092
21. Centers for Disease Control and Prevention (CDC). Ebola viral disease outbreak-West Africa, 2014. MMWR Morb Mortal Wkly Rep. 2014; 63: 548-551
22. Mupapa K, Mukundu W, Bwaka MA, et al. Ebola hemorrhagic fever and pregnancy. J Infect Dis. 1999; 179 (Suppl 1): S11-S12
23. McElroy AK, Erickson BR, Flietstra TD, et al. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis. 2014; 210: 558-566
24. McElroy AK, Erickson BR, Flietstra TD, et al. Biomarker correlates of survival in pediatric patients with Ebola virus disease. Emerg Infect Dis. 2014; 20: 1683-1690
25. Bray M. Diagnosis and treatment of Ebola and Marburg virus disease 2014. Accessed September 18, 2014
26. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission De Lutte contre les Epidémies à Kikwit. J Infect Dis. 1999; 179(Suppl 1): S28-S35
27. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007; 196: S142-147
28. Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999; 179(Suppl 1): S170-176
29. Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014; 514: 47-53
30. Fauci AS. Ebola-underscoring the global disparities in health care resources. N Engl J Med. 2014; 371: 1084-1086
31. Geisbert TW. Medical research: Ebola therapy protects severely ill monkeys. Nature. 2014; 514: 41-43
32. WHO. Consultation on potential Ebola therapies and vaccines-background document for participants 2014. Available at: http://www.who.int/csr/disease/ebola/ebola-new-interventions-02-sep-2014.pdf?ua=1. Accessed October 15, 2014
33. Centers for Disease Control and Prevention (CDC). Infection prevention and control recommendations for hospitalized patients with known or suspected Ebola hemorrhagic fever in US hospitals 2014. Available at: http://www. cdc.gov/vhf/ebola/hcp/infection-prevention-And-control-recommendations. html. Accessed September 19, 2014
34. Mupapa K, Massamba M, Kibadi K, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis. 1999; 179(Suppl 1): S18-S23
35. Sadek RF, Khan AS, Stevens G, Peters CJ, Ksiazek TG. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis. 1999; 179(Suppl 1): S24-27
36. World Health Organization (WHO). Statement on the WHO consultation on potential Ebola therapies and vaccines 2014. Available at: http://www. who.int/mediacentre/news/statements/2014/ebola-Therapies-consultation/en/. Accessed September 22, 2014
37. Centers for Disease Control and Prevention (CDC). Interim guidance for environmental infection control in hospitals for Ebola virus 2014. Available at: http://www.cdc.gov/vhf/ebola/hcp/environmental-infection-control-inhospitals. html. Accessed September 28, 2014
38. Centers for Disease Control and Prevention (CDC). Interim guidance for the U.S. residence decontamination for Ebola virus disease (Ebola) and removal of contaminated waste 2014. Available at: http://www.cdc.gov/vhf/ebola/hcp/residental-decontamination.html. Accessed November 10, 2014
39. Borchert M, Mutyaba I, Van Kerkhove MD, et al. Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned. BMC Infect Dis. 2011; 11: 357
40. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014; 371: 1418-1425
41. Mupere E, Kaducu OF, Yoti Z. Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci. 2001; 1: 60-65
42. Dowell SF. Ebola hemorrhagic fever: why were children spared?. Pediatr Infect Dis J. 1996; 15: 189-191
43. World Health Organization (WHO). Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978; 56: 271-293
44. Jamieson DJ, Uyeki TM, Callahan WM, et al. What obstetricians-gynecologists should know about Ebola; a perspective from the Centers for Disease Control and Prevention. Obst Gynecol. 2014; 124: 1005-1010
45. Chevalier MS, Chung W, Smith J, et al; Centers for Disease Control and Prevention (CDC). Ebola virus disease cluster in the United States-Dallas County, Texas, 2014. MMWR Morb Mortal Wkly Rep. 2014; 63: 1087-1088
46. Wilson ME. Fever in returned travelers. In: Brunette GW, Kozarsky PE, eds. CDC Health Information for International Travel 2014. New York, NY: Oxford University Press; 2014
47. Centers for Disease Control and Prevention (CDC). Case definition for Ebola virus disease 2014. Available at: http://www.cdc.gov/vhf/ebola/hcp/case-definition.html. Accessed November19, 2014
48. Centers for Disease Control and Prevention (CDC). Interim guidance for monitoring and movement of persons with Ebola virus disease exposure 2014. Available at: http://www.cdc.gov/vhf/ebola/hcp/monitoring-Andmovement- of-persons-with-exposure.html. Accessed November 30, 2014
49. Centers for Disease Control and Prevention (CDC). Epidemiologic risk factors to consider when evaluating a person for exposure to Ebola virus 2014. Available at: http://www.cdc.gov/vhf/ebola/exposure/risk-factorswhen- evaluating-person-for-exposure.html. Accessed November 10, 2014
50. Centers for Disease Control and Prevention (CDC). When caring for suspect or confirmed patients with Ebola. Available at: http://www.cdc.gov/vhf/ebola/hcp/caring-for-ebola-suspects.html. Accessed November 10, 2014
51. Centers for Disease Control and Prevention (CDC). Interim guidance for specimen collection, transport, testing, and submission for persons under investigation for ebola virus disease in the United States 2014. Available at: http://www. cdc.gov/vhf/ebola/hcp/interim-guidance-specimen-collection-submissionpatients- suspected-infection-ebola.html. Accessed November 15, 2014
52. Eba PM. Ebola and human rights in West Africa. Lancet 2014; 384: 2091-2093